U.S. Overactive Bladder Market
U.S. Overactive Bladder Market
RELEASE DATE
13-Nov-2009
13-Nov-2009
REGION
North America
North America
Research Code: N695-01-00-00-00
SKU: HC02132-NA-MR_07682
$4,950.00
In stock
SKU
HC02132-NA-MR_07682
Description
This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.
Table of Contents
U.S. Overactive Bladder Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Product Analysis
- Product Comparisons
- Recently Approved Products
Pipeline Analysis
- Phase III
- Phase II
- Phase I
Overview
Forecasts and Trends
Market Share Analysis
Decision Support Databases
Popular Topics
This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N695-01-00-00-00 |
Is Prebook | No |